FDA Import Refusal 1FX-3165589-8/50002/1 — Logos Pharma
The FDA refused shipment 1FX-3165589-8/50002/1 from Logos Pharma (India) on Sep 18, 2026. The refused product falls under Drugs and Biologics — LETROZOLE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ICY85 LETROZOLE (ANTI-NEOPLASTIC)
- Charges
- 75